News about the B-specific project at the ULEI website
News about the B-specific project at the ULEI website
Preventing heart attacks by earlier detection of cardiovascular disease
Visit from Harteraad
InnovationActa
On the 30th of November 2023 Prof. Ilze Bot organized an event at the Leiden Academic Centre for Drug Research (LACDR) (Leiden University, The Netherlands) inviting the representatives of Harteraad (Dutch patient organization) which represents the interests of about 1.7 million people with cardiovascular disease.
The event included a site visit, presentations, and lab tour. Besides Prof. Ilze Bot, Assoc. Profs. Amanda Foks and Bram Slütter actively participated in the meeting and presented their research.
The title of the presentation introducing the B-specific project was ‘Het verouderde afweersysteem in slagaderverkalking: een nieuwe biomarker of behandeling?’ (English translation: The aged immune system in atherosclerosis: a new biomarker or treatment?)
Kick Off Meeting 2023
23rd October 2023
Faculty Club, Rapenburg 73
Leiden - Netherlands
The B-specific consortium led by Amanda Foks (Leiden Academic Centre for Drug Research, Leiden University, The Netherlands) successfully kicked-off the project B-specific (B-cell related gene and protein markers with prognostic and therapeutic value for CVD). The event was held on the 23rd of October 2023 at the Faculty Club (Academy Building) in Leiden (The Netherlands). Thanks to European Innovation Council (EIC) (Grant Nr. 101115159) for supporting the research to discover new biomarkers and therapeutic targets for atherosclerosis.